U.S. News & World Report?and its partner Doximity have opened their annual physician survey to help determine the 2024-25 America’s Best Hospitals and specialty rankings.
At UCI Health, we are pioneering transformative care in neurology and neurosurgery, integrating cutting-edge treatments, breakthrough research, and exceptional patient-centered care.
This year, our Comprehensive Stroke Center earned the Get with the Guidelines®-Stroke Gold Plus Award and a place on the Stroke Elite Plus Honor Roll, recognizing our commitment to rapid, evidence-based stroke treatment. Our Epilepsy Center continues as an NAEC-designated Level 4 Center, while our Multiple Sclerosis, Huntington’s Disease, and ALS programs are all nationally recognized Centers of Excellence.
Our faculty are leading groundbreaking clinical trials in CAR-T therapy for glioblastoma, next-generation Alzheimer’s treatments, and precision neurology programs incorporating genetics and biomarker-driven diagnostics. We also continue to grow, with expanded neurogenetics, neuroinformatics, and traumatic brain injury programs, ensuring our community has access to the most comprehensive neurological care in Southern California.
If you are a board-certified physician with a Doximity profile, you should have received an email inviting you to cast a vote for a hospital that excels in your specialty. As your trusted colleagues, we hope you will consider selecting UCI Medical Center in the U.S. News & World Report reputation survey.
Message from the chairs:
Frank Hsu, MD
Chair, Department of Neurological Surgery
Claire Henchcliffe, MD, DPhil
Chair, Department of Neurology
UCI Health is home to more than 70 expert faculty, including clinicians, clinician-scientists, and translational researchers dedicated to pioneering advances in neurosurgical and neurological care.
We are proud to share that:
We have over 100 ongoing clinical trials, including new stem cell, gene therapy, and immunotherapy trials for neurodegenerative diseases and brain cancer.
Our department receives over $50 million in research funding, half from federal agencies such as the NIH.
Our faculty have published over 150 manuscripts in peer-reviewed journals over the last year.
We are expanding clinical neuroscience by 40%, launching new programs in traumatic brain injury, neurogenetics, and neuroinformatics. The UCI Health Comprehensive Spine Center continues to lead in minimally invasive and robotic-assisted spine surgery, offering advanced care for spinal tumors, vascular malformations, and degenerative disease.
We are at the forefront of minimally invasive brain surgery, utilizing robotics, neuro-navigation, and focused ultrasound to reduce recovery times and improve outcomes.
Centers of Excellence and National Recognition:
Comprehensive Stroke Center – Get with the Guidelines®-Stroke Gold Plus & Elite Plus Honor Roll
Level 4 Epilepsy Center – National Association of Epilepsy Centers (NAEC)
Multiple Sclerosis Center of Excellence – National MS Society
Huntington’s Disease Center of Excellence – Huntington’s Disease Society of America
ALS Clinic – Muscular Dystrophy Association (MDA) designated
Innovation and Expansion:
Improving Dementia Diagnosis – UCI was awarded an $8 million NIH grant to study LATE, a recently identified Alzheimer’s mimic that may account for up to 40% of dementia cases.
Undiagnosed Diseases Network (UDN) – UCI and CHOC received an NIH $3.2 million grant to help patients with rare neurological disorders find answers and treatment.
Brain-Computer Interfaces – Our teams are developing next-generation neuroprosthetics to restore function after stroke and spinal cord injury, with a $2 million NSF grant supporting biocomputer research.
Expanded Clinical Access – UCI Health neurology and neurosurgery now provides comprehensive care at the new Chao Family Comprehensive Cancer Center and the Joe C. Wen & Family Center for Advanced Care in Irvine.
As we continue to grow and innovate, we remain committed to delivering world-class care and developing the future of neurosciences.